Myomo (NYSE:MYO) shares took a hit today on fourth-quarter results that came up short of the consensus forecast. Shares of MYO fell 10% to $3.16 apiece in mid-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — ticked up 0.5%. The Boston-based wearable exoskeleton maker posted […]
myomo
Myomo to raise $6M with eyes on Medicare coverage
Myomo (NYSE:MYO) announced today that it entered into securities purchase agreements worth approximately $6 million. The company entered into agreements with certain new and existing institutional investors, plus insiders at Myomo. This agreement includes nearly 1.6 million shares of common stock priced at $3.80 per share. In conjunction with the offering, Myomo disclosed that it […]
Myomo closes $4.4M public offering
Myomo (NYSE:MYO) announced today that it closed its previously announced offering worth proceeds of approximately $4.4 million. The Boston-based wearable medical robotics maker priced its “reasonable best efforts” public offering last week. It included more than 7.3 million shares of common stock priced at 60¢ per share. Members of management, affiliated investors and certain high-quality, […]
Myomo prices $4.4M offering, scores reimbursement win
Myomo (NYSE:MYO) announced today that it priced a “reasonable best efforts” public offering worth proceeds of approximately $4.4 million. Boston-based Myomo’s offering includes more than 7.3 million shares of common stock priced at 60¢ per share. The company expects to close the offering on or about Aug. 29, 2023, subject to customary conditions. Myomo develops […]
ReWalk Robotics, Myomo to benefit from new proposed Medicare classifications
A new proposed rule from the Centers for Medicare and Medicaid Services (CMS) could benefit companies like ReWalk Robotics (Nasdaq:RWLK) and Myomo (NYSE:MYO). The proposed rule would establish a new regulatory definition of “brace.” In Myomo’s case, it aims to classify the L8701 and L8702 HCPCS codes as “brace.” Adding the definition of brace would […]
Myomo prices $6.5M public offering
Myomo (NYSE:MYO) announced today that it priced a public offering of 20 million shares of common stock at $0.325 per share. Boston-based Myomo expects aggregate gross proceeds to total approximately $6.5 million. That comes before deducting placement agent fees and other offering expenses. The company expects the offering to close on or about Jan. 17, […]
Myomo slides as Q4 earnings miss despite massive sales beat
Myomo (NYSE:MYO) shares were down this morning on fourth-quarter results that were mixed compared to the consensus forecast. The Boston-based medical robotics company posted losses of $2.7 million, or 52¢ per share, on sales of $4 million for the three months ended Dec. 31, 2021, for a bottom-line slide deeper into the red on sales […]
Myomo touts independent study of its MyoPro myoelectric orthosis
Myomo (NYSE:MYO) announced today that new research demonstrated benefits with its MyoPro myolectric orthosis for the upper limbs. Results from the study, funded by the U.S. Army Medical Research Acquisition Activity, and supported by the Office of Secretary of Defense for Health Affairs, were published in the peer-reviewed journal Frontiers in Neurology. Data showed “statistically significant improvements” […]
Myomo skyrockets after hours on Street-beating Q3
Myomo (NYSE:MYO) shares got a big boost after hours today on third-quarter results that came in ahead of the consensus forecast. MYO shares were up 10.9% at $11.52 per share after hours. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — closed the day down 0.9%. The Boston-based […]
Myomo ticks up on Street-beating Q2 results
Myomo (NYSE:MYO) posted second-quarter results this week that beat the overall consensus on Wall Street. The Boston-based medical robotics company — maker of MyoPro powered arm braces — reported losses of -$2.6 million, or -46¢ per share, on sales of $3.1 million for the three months ended June 30, for a sales growth of 261.56% compared […]
Myomo rises on Street-beating Q4
Myomo (NYSE:MYO) shares ticked up this morning on fourth-quarter results that topped the consensus forecast. The Boston-based wearable medical robotics company posted losses of -$1.7 million, or -37¢ per share, on sales of $3.8 million for the three months ended Dec. 31, 2020, for a 38.5% bottom-line gain on revenues that were more than doubled […]